Department of Chemistry & Education, Seoul National University , Seoul 08826, Korea.
Department of Chemistry, Seoul National University , Seoul 08826, Korea.
Biomacromolecules. 2016 Sep 12;17(9):3007-15. doi: 10.1021/acs.biomac.6b00874. Epub 2016 Jul 29.
Cell-penetrating peptides (CPPs) often have cationic and amphipathic characteristics that are commonly associated with α-helical peptides. These features give CPPs both membrane demolishing and penetrating abilities. To make CPPs safe for biomedical applications, their toxicities resulting from their membrane demolishing abilities must be removed while their cell penetrating abilities must be retained. In this study, we systematically constructed mutants of the amphipathic α-helical model peptide (LKKLLKLLKKLLKLAG, LK peptide). The hydrophobic amino acid leucine in the LK peptide was replaced with hydrophilic amino acids to reduce hemolytic or cell toxicity. Most of the mutants were found to have weakened membrane disrupting abilities, but their cell penetrating abilities were also weakened. However, the L8Q and L8K mutants were found to have low micromolar range cell penetrating ability and almost no membrane disrupting ability. These selected mutants utilize energy-dependent endocytosis mechanisms instead of an energy-independent direct cell penetrating mechanism to enter cells. In addition, the mutants can be used to deliver the anticancer drug methotrexate (MTX) to cells, thereby overcoming resistance to this drug. To determine if the effect of these mutations on the membrane disrupting and cell penetrating abilities is general, Q and K mutations of the natural amphipathic α-helical antimicrobial peptide (AMP), LL37, were introduced. Specific positional Q and K mutants of LL37 were found to have lower hemolytic toxicities and preserved the ability to penetrate eukaryotic cells such as MDA-MB-231 cells. Taken together, observations made in this work suggest that interrupting the global hydrophobicity of amphipathic α-helical CPPs and AMPs, by replacing hydrophobic residues with mildly hydrophilic amino acids such as Q and K, might be an ideal strategy for constructing peptides that have strong cell penetrating abilities and weak cell membrane disrupting abilities.
细胞穿透肽 (CPPs) 通常具有阳离子和两亲性特征,这通常与 α-螺旋肽有关。这些特性使 CPPs 具有破坏膜和穿透膜的能力。为了使 CPPs 能够安全地用于生物医学应用,必须消除其破坏膜的能力所带来的毒性,同时保留其穿透细胞的能力。在这项研究中,我们系统地构建了两亲性 α-螺旋模型肽 (LKKLLKLLKKLLKLAG,LK 肽) 的突变体。LK 肽中的疏水性氨基酸亮氨酸被亲水氨基酸取代,以降低溶血或细胞毒性。大多数突变体的膜破坏能力减弱,但它们的细胞穿透能力也减弱。然而,L8Q 和 L8K 突变体被发现具有低微摩尔范围的细胞穿透能力,几乎没有膜破坏能力。这些选择的突变体利用能量依赖的内吞作用机制而不是非能量依赖的直接细胞穿透机制进入细胞。此外,这些突变体可用于将抗癌药物甲氨蝶呤 (MTX) 递送至细胞,从而克服对该药物的耐药性。为了确定这些突变对膜破坏和细胞穿透能力的影响是否具有普遍性,引入了天然两亲性 α-螺旋抗菌肽 (AMP) LL37 的 Q 和 K 突变。发现 LL37 的特定位置 Q 和 K 突变体的溶血毒性降低,并保持穿透真核细胞(如 MDA-MB-231 细胞)的能力。总之,这项工作中的观察结果表明,通过用轻度亲水氨基酸(如 Q 和 K)取代疏水性残基来中断两亲性 α-螺旋 CPPs 和 AMPs 的整体疏水性,可能是构建具有强细胞穿透能力和弱细胞膜破坏能力的肽的理想策略。